pbio.3002249.s014.docx (13.85 kB)
Characteristics of patients included in the analyses.
journal contribution
posted on 2023-12-21, 18:25 authored by Bach Tran Nguyen, Aurélien Marc, Clara Suñer, Michael Marks, Maria Ubals, Águeda Hernández-Rodríguez, María Ángeles Melendez, Dennis E. Hruby, Andrew T. Russo, France Mentré, Oriol Mitjà, Douglas W. Grosenbach, Jérémie GuedjData shown as n (%) or median (IQR); *No participants had a CD4 cell count lower than 100 cells/μL; **Highest count of lesions during the follow-up period.
(DOCX)
History
Usage metrics
Categories
Keywords
54 untreated patientsestimated mpox withindrug steady statepositive viral culturepharmacological model developeddiv >< pviral dynamic modelcharacterize mpox kineticsviral kineticsmpox infectiondrug administrationviral peakmpox clearanceviral clearanceunique setsymptom onsetskin lesionsrecommended dosesnonhuman primatesmodeling frameworkinitiating treatmentinfection dayinfected cellsideally startinghealthy volunteersfindings supportearly administrationdespite usecould reduceantiviral effect2022 outbreak10 days0 log
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC